Ionis Pharmaceuticals, Inc. IONS announced that the FDA has granted a Fast Track designation to its investigational RNA-targeted therapy zilganersen for treating Alexander disease (AxD), an ultra-rare...
Ionis Pharmaceuticals: Q2 Earnings Snapshot
Ionis Pharmaceuticals: Q1 Earnings Snapshot
Ionis Pharmaceuticals: Q4 Earnings Snapshot
Morning Markets March E-Mini S&P 500 futures (ESH24 ) are up +0.35%, and March Nasdaq 100 E-Mini futures (NQH24 ) are up +0.57%, both at new all-time nearest-futures highs. Stock index futures this morning...
Ionis Pharmaceuticals: Q3 Earnings Snapshot
/PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that it will host a live webcast on Thursday, November 2nd at 11:30 a.m. Eastern...
With experienced commercial team in place, Ionis poised to independently bring steady cadence of potentially transformational RNA-targeted medicines to...
/PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that The Journal of the American Medical Association (JAMA) published positive...